Novavax Inc

Novavax Inc is a biotech firm that specializes in developing vaccines for infectious diseases. Their proprietary technology platform enables the swift production of vaccines using virus-like particles (VLPs). The company's primary focus is on creating a vaccine for respiratory syncytial virus (RSV), a common cause of respiratory illness in infants and the elderly. Novavax is also working on vaccines for seasonal influenza, Ebola, and COVID-19. Novavax has partnered with various organizations, including the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill and Melinda Gates Foundation. The company is headquartered in Gaithersburg, Maryland, with additional facilities in Europe and India. Novavax is dedicated to enhancing global health by providing safe and effective vaccines to prevent the spread of infectious diseases.